That is a big problem. I believe we have already discussed that here, with other witnesses, in the past.
We need to expand our businesses further. With regard to R&D tax credits, the OECD and other, Canadian observers have said that, in Canada, even if we take into account the SR&ED program tax credit, we are moving from a non-refundable tax credit of 20% to a refundable tax credit of 35%, depending on the size of the business. And it does not take much to cross that line. In fact, we are using the definition of a Canadian-controlled private corporation. I believe that means taxable income in the order of $400,000.
This leads some people, such as Mark Pearson, of PricewaterhouseCoopers, who published a report last year, to say that this is virtually an obstacle to the growth of small businesses. If they suddenly exceed that level in one year, they lose 15% of their tax credits. If they are not in a profitable position, they will no longer have access to the refund.
In the report it published before the summer, the OECD said that you should slightly reduce tax credits for small business and reallocate them to direct support activities, in particular to provide some harmonization of the tax credit offered to all businesses. To answer your question, I would say that the OECD found that it was much more important to provide direct support for small businesses because assistance is often needed in research pre-commercialization or commercialization activities.
The tax credit may be more important for large businesses in that they have much more mobile capital than small businesses. As I said earlier, multinationals have the ability to go to the most favourable places, whereas the smallest businesses may perhaps not have that ability.